News Release


CIMC Cold Cloud Supported the Export of One Million Doses of the First Domestic 13-Valent Pneumococcal Vaccine


Recently, one million doses of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (“13-Valent Pneumococcal Vaccine”) in the intelligent medical cold-chain temperature control boxes of CIMC Cold Cloud arrived in Morocco in batches. The vaccine, independently developed by Walvax Biotechnology, is the first 13-Valent Pneumococcal Vaccine in China and the second 13-Valent Pneumococcal Vaccine in the world. Such export is the first export of the vaccine after its marketing.

It is known that the 13-Valent Pneumococcal Vaccine was approved for marketing in 2019, ending the monopoly held by foreign enterprises for more than a decade. The vaccine has been included in the expanded immunization program in Morocco to protect millions of children from life-threatening diseases.

CIMC Cold Cloud provided temperature control packaging solutions for the one million doses of the pneumonia vaccine with a total weight of 80 tons delivered to Morocco. CIMC Cold Cloud XT series of passive cooling and temperature control boxes feature a large body and light weight, high loading rate, easy loading and unloading at the bottom of the tray, and temperature control duration of more than 150 hours. This product also has many high-quality service cases in the export of domestically produced COVID-19 vaccines and reagents, and is more suitable for lengthy cold chain transportation of vaccines or medicines in large quantities.

CIMC Cold Cloud is one of the first key COVID-19 vaccine transportation enterprises publicized by the Ministry of Transport, and has participated in the drafting and preparation of many national and industrial standards such as the Technical Guide for Road Transportation of COVID-19 Vaccines and the Operation Standards of Pharmaceutical Cold Chain Logistics. It has rich operational experience in the industry. By the end of 2021, CIMC Cold Cloud delivered reagents and clinical drugs to a total of more than 100 countries and regions all over the world, helping the export of domestic COVID-19 vaccines to over 40 countries, with the total quantity exceeding 600 million doses. International pharmaceutical cold chain services include cold chain packaging design, encasing, inland transportation, airport customs declaration, airport operation and other services, covering the whole process from clinical trial to marketing. According to the different characteristics of products, it can provide a variety of temperature control solutions such as normal temperature (15℃-25℃), cold storage (2℃-8℃) and freezing (-25℃ -15℃), and stable, safe and timely cold chain packaging and transportation services, thus winning praise from customers at home and abroad.